Study shows transplanted heart aging reversal and US approves first Chinese in vivo CAR-T trial
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
A preprint study shows that transplanted heart tissues change DNA methylation to match their recipient's biological age. Meanwhile, the US FDA approved its first clinical trial for a China-developed in vivo CAR-T-cell therapy treating blood cancers, highlighting China's rapid rise in the field.
Continue in the app — vote & join in ➔Source: Nature News · via ahirlevel.hu